Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kura Oncology stock

Learn how to easily invest in Kura Oncology stock.

Kura Oncology is a biotechnology business based in the US. Kura Oncology shares (KURA) are listed on the NASDAQ and all prices are listed in US Dollars. Kura Oncology employs 127 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Kura Oncology stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – KURA. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Kura Oncology stock price (NASDAQ: KURA)

Use our graph to track the performance of KURA stocks over time.

Kura Oncology shares at a glance

Information last updated 2023-01-25.
Latest market close$14.60
52-week range$10.41 - $19.93
50-day moving average $13.80
200-day moving average $14.62
Wall St. target price$32.22
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.99

Buy Kura Oncology stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Kura Oncology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kura Oncology price performance over time

Historical closes compared with the close of $14.6 from 2023-01-25

1 week (2023-01-20) 4.81%
1 month (2022-12-27) 30.01%
3 months (2022-10-27) -5.32%
6 months (2022-07-27) -10.26%
1 year (2022-01-23) N/A
2 years (2021-01-27) -50.89%
3 years (2020-01-27) 24.57%
5 years (2018-01-26) 19.95

Kura Oncology financials

Gross profit TTM $0
Return on assets TTM -17.06%
Return on equity TTM -28.42%
Profit margin 0%
Book value $6.27
Market capitalisation $982.2 million

TTM: trailing 12 months

Kura Oncology share dividends

We're not expecting Kura Oncology to pay a dividend over the next 12 months.

Kura Oncology share price volatility

Over the last 12 months, Kura Oncology's shares have ranged in value from as little as $10.41 up to $19.93. A popular way to gauge a stock's volatility is its "beta".

KURA.US volatility(beta: 0.83)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kura Oncology's is 0.8322. This would suggest that Kura Oncology's shares are less volatile than average (for this exchange).

Kura Oncology overview

Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

Frequently asked questions

What percentage of Kura Oncology is owned by insiders or institutions?
Currently 2.71% of Kura Oncology shares are held by insiders and 109.193% by institutions.
How many people work for Kura Oncology?
Latest data suggests 127 work at Kura Oncology.
When does the fiscal year end for Kura Oncology?
Kura Oncology's fiscal year ends in December.
Where is Kura Oncology based?
Kura Oncology's address is: 12730 High Bluff Drive, San Diego, CA, United States, 92130
What is Kura Oncology's ISIN number?
Kura Oncology's international securities identification number is: US50127T1097
What is Kura Oncology's CUSIP number?
Kura Oncology's Committee on Uniform Securities Identification Procedures number is: 50127T109

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site